Coming soon via email and U.S. mail – Blue KC’s plan year 2022 Consolidated Appropriations Act (CAA) prescription drug data collection (RxDC) reporting survey.
In late March, Blue KC will mail you and your group contacts a letter about the survey, which will include a link to the survey. The survey will closely resemble the one distributed in the fall. While submission was optional in the fall, this year’s submission is required, and the government plans to take compliance measures against nonadherence.
Please work with your groups to collect the required premium information and other data necessary on the survey.
You can visit the Center’s for Medicare & Medicaid Services RxDC page for more information.